Pharmidex will attend Genesis 2025 hosted by One Nucleus
December 2, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM), and our Dr. Ian Knowles, will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus.
They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development.
See you at Genesis 2025!
#Pharmidex #Genesis2025 #OneNucleus #DrugDiscovery #LifeSciences
Advanced Therapies Integrates 2025
The Pharmidex team will be in London for London Life Sciences Week from the 16th. Janette Dalay Robertson and Ash Alavijeh will be attending a range of events across the week. We are looking forward to a busy week discussing all things life-science related. Get in touch if you’d like to meet with us during the week as we visit existing clients and stakeholders!
Our Head of Integrated Therapeutics and CNS, Dr. Stephen Mitchell , our Business Development Manager, Janette Dalay Robertson and our Senior Research Scientist in CNS, Jewel Ahmed will be there to engage with attendees, share insights and explore new collaborations driving innovation in Parkinson’s disease drug discovery and development. If you’re attending, don’t hesitate to reach out, they’ll be delighted to connect and discuss how Pharmidex’s integrated expertise can help move your research from concept to clinic.
